Product Information
METHYLPHENIDATE 5 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1309 per EA under NDC 67877061601. Its NADAC has been published 260 times since Sep 1, 2021.
FDA first approved this application on Oct 4, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877061601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211779FDA Approved
10/4/2019
TE Code
AB
On Market Since
10/6/2019
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 5 MG TABLET has been published 260 times since Sep 1, 2021, and over the history we have for it it has risen 9.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1309 per EA |
|---|---|
| All-time high | $0.1434 (Feb 11, 2026) |
| All-time low | $0.0841 (Jul 17, 2024) |
| 52-week high | $0.1434 |
| 52-week low | $0.1309 |
| Median price | $0.1118 |
| Average price | $0.1164 |
| Largest weekly change | +55.5% (Aug 21, 2024) |
| Weeks tracked | 260 |
| Tracking since | Sep 1, 2021 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 5 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.1309 per EA (NDC 67877061601), effective Aug 19, 2026.
How has the price of METHYLPHENIDATE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 5 MG TABLET has risen 9.4%. It has been tracked across 260 weekly CMS publications since Sep 1, 2021.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 5 MG TABLET?
Since Sep 1, 2021, the NADAC for METHYLPHENIDATE 5 MG TABLET has ranged from a low of $0.0841 (Jul 17, 2024) to a high of $0.1434 (Feb 11, 2026), with a median of $0.1118 per EA.
Are there cheaper alternatives to METHYLPHENIDATE 5 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE 5 MG TABLET, is $0.0858 per EA — about 34% below METHYLPHENIDATE 5 MG TABLET.
Who manufactures METHYLPHENIDATE 5 MG TABLET?
METHYLPHENIDATE 5 MG TABLET (NDC 67877061601) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.